![Texas Lab Settles Kickback Allegations for $5.9M](https://www.g2intelligence.com/wp-content/uploads/2023/04/Apr5-2023.News_.WeeklyEnforcementReport-Settlements-iStock-1100x800-1-1080x675.jpg)
Texas Lab Settles Kickback Allegations for $5.9M
Last week saw three key settlements, including a lab accused of paying kickbacks for test referrals and billing for unnecessary drug tests.
Last week saw three key settlements, including a lab accused of paying kickbacks for test referrals and billing for unnecessary drug tests.
The U.S. Department of Justice recently announced inflationary increases to civil monetary penalties under the False Claims Act.
Labs have a duty to inquire into what their billing company is up to and whether it complies with all applicable regulations.
This week’s cases involved false billing allegations related to urine drug testing, as well as diagnostic imaging false claims and fraud.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.